Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Temozolomide · Temodar, CCRG-81045

Small molecule · Cytotoxic, directed at guanine (DNA) · developed by Merck Sharp Dohme

Approved FDA, Aug 1999
1 Registered trials

What is Temozolomide?

Temodar (temozolomide) is an oral alkylating agent that converts nonenzymatically at physiologic pH to MTIC, which methylates DNA mainly at the O6 and N7 positions of guanine, causing DNA double-strand breaks and cell death. It is used in the treatment of glioblastoma and anaplastic astrocytoma, and is studied in other glioma and brain tumor types.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Temodar, CCRG-81045, M-39831
Drug type
Small molecule
Targets
guanine (DNA)
Mechanism
Cytotoxic, directed at guanine (DNA)
Pathways
DNA alkylation, DNA double strand breaks, programmed cell death
Therapy area
Oncology
Developer
Merck Sharp Dohme
In trials of
RIGL
FDA status
Approved as Temodar (August 11, 1999), NDA021029 · FDA label
UNII
YF1K15M17Y

✅ FDA-approved uses

From the indications section of the FDA label (version of Feb 20, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06161974 Phase 2 High Grade Glioma Recruiting RIGL

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

AstrocytomaAstrocytoma, Grade IIIAstrocytoma, Grade IVDiffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3 K27M-MutantHigh Grade GliomaIDH1 MutationIDH1 R132IDH1 R132CIDH1 R132HMetastatic Brain TumorSpinal TumorThalamus TumorWHO Grade III Glioma

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.